Adial Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ADIL and other ETFs, options, and stocks.About ADIL
Adial Pharmaceuticals, Inc. engages in the development of therapeutics for the treatment or prevention of addiction and related disorders. It offers the AD04, a selective serotonin-3 antagonist.
CEOCary J. Claiborne
CEOCary J. Claiborne
Employees7
Employees7
HeadquartersGlen Allen, Virginia
HeadquartersGlen Allen, Virginia
Founded2010
Founded2010
Employees7
Employees7
ADIL Key Statistics
Market cap7.15M
Market cap7.15M
Price-Earnings ratio-0.33
Price-Earnings ratio-0.33
Dividend yield—
Dividend yield—
Average volume251.32K
Average volume251.32K
High today$0.3293
High today$0.3293
Low today$0.29
Low today$0.29
Open price$0.31
Open price$0.31
Volume134.37K
Volume134.37K
52 Week high$1.30
52 Week high$1.30
52 Week low$0.22
52 Week low$0.22
Stock Snapshot
As of today, Adial Pharmaceuticals(ADIL) shares are valued at $0.29. The company's market cap stands at 7.15M, with a P/E ratio of -0.33.
On 2025-12-11, Adial Pharmaceuticals(ADIL) stock traded between a low of $0.29 and a high of $0.33. Shares are currently priced at $0.29, which is +0.1% above the low and -11.8% below the high.
The Adial Pharmaceuticals(ADIL)'s current trading volume is 134.37K, compared to an average daily volume of 251.32K.
During the past year, Adial Pharmaceuticals(ADIL) stock moved between $0.22 at its lowest and $1.30 at its peak.
During the past year, Adial Pharmaceuticals(ADIL) stock moved between $0.22 at its lowest and $1.30 at its peak.
People also own
Based on the portfolios of people who own ADIL. This list is generated using Robinhood data, and it’s not a recommendation.